Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Nitrofurantoin
Drug ID BADD_D01576
Description Nitrofurantoin is a nitrofuran antibiotic used to treat uncomplicated urinary tract infections.[L6856,L6859,L6862] Nitrofurantoin is converted by bacterial nitroreductases to electrophilic intermediates which inhibit the citric acid cycle as well as synthesis of DNA, RNA, and protein.[A179824] This drug is more resistant to the development of bacterial resistance because it acts on many targets at once.[A179824] Nitrofurantoin is a second line treatment to [trimethoprim]/[sulfamethoxazole].[A179830] Nitrofurantoin was granted FDA approval on 6 February 1953.[L6895]
Indications and Usage Nitrofurantoin is indicated to treat acute uncomplicated urinary tract infections.[L6856,L6859,L6862]
Marketing Status approved; vet_approved
ATC Code J01XE01
DrugBank ID DB00698
KEGG ID D00439
MeSH ID D009582
PubChem ID 6604200
TTD Drug ID D0R0BX
NDC Product Code 0591-3685; 48087-0009; 62332-390; 62332-391; 70954-496; 72189-179; 48087-0029; 51927-5024; 46708-390; 67296-1442; 70408-239; 71205-370; 48087-0097; 48087-0148; 68071-2281; 68788-8258; 63629-2464; 65162-689; 0591-3684; 46708-391; 68071-2928; 0472-1992; 70199-036; 70518-3717; 71205-365; 48087-0081; 48087-0147; 13811-719; 71205-852; 48087-0146; 60862-006; 40032-450; 60687-483; 68071-2956; 71335-0878; 59651-206; 61919-458; 62332-389; 71052-240; 16571-888; 64980-593; 16571-740; 43386-450; 46708-389; 60687-472; 68001-423; 70199-006; 0591-3686
UNII 927AH8112L
Synonyms Nitrofurantoin | Furadoine | Nitrofurantoin, Monohydrate | Furantoin | Macrodantin | Nitrofurantoin Sodium Salt | Furadantin | Furadantine | Furadonine
Chemical Information
Molecular Formula C8H6N4O5
CAS Registry Number 67-20-9
SMILES C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hepatitis chronic active11.07.01.002; 09.01.07.006--Not Available
Hepatomegaly09.01.05.001--Not Available
Hyperaesthesia23.03.03.080; 17.02.06.004--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypersensitivity10.01.03.003--
Hypersomnia19.02.05.001; 17.15.01.001--
Hypoaesthesia23.03.03.081; 17.02.06.023--Not Available
Hypokinesia17.01.02.009--Not Available
Hypotension24.06.03.0020.000121%
Hypoxia22.02.02.0030.000121%
Influenza like illness08.01.03.010--
Interstitial lung disease22.01.02.003; 10.02.01.0330.000149%Not Available
Jaundice01.06.04.004; 23.03.03.030; 09.01.01.004--Not Available
Jaundice cholestatic09.01.01.005--Not Available
Joint swelling15.01.02.004--Not Available
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Leukocytosis01.02.01.002--
Leukopenia01.02.02.001--Not Available
Lip swelling23.04.01.007; 10.01.05.005; 07.05.04.005--Not Available
Liver disorder09.01.08.001--Not Available
Lung disorder22.02.07.001--Not Available
Lung infiltration22.01.02.004--Not Available
Malaise08.01.01.003--
Methaemoglobinaemia01.05.01.002--
Muscle atrophy17.05.03.004; 15.05.03.003--Not Available
Muscle spasms15.05.03.004--
Muscular weakness15.05.06.001; 17.05.03.005--
Myalgia15.05.02.001--
Nausea07.01.07.0010.000110%
Neck pain15.03.04.009--
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 8 Pages